Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
The National Centre in HIV Epidemiology and Clinical Research Abbott Boehringer Ingelheim Pharmaceuticals GlaxoSmithKline Bristol-Myers Squibb Merck Hoffmann-La Roche Virco Diagnostic Technology Perkin Elmer Biosystems |
---|---|
Information provided by: | The National Centre in HIV Epidemiology and Clinical Research |
ClinicalTrials.gov Identifier: | NCT00262717 |
To compare two commercially available platforms for assessment of HIV drug resistance to determine which provides superior virological results.
We hypothesise that one test will be significantly superior to the other.
Condition | Intervention | Phase |
---|---|---|
HIV Infection |
Device: HIV drug resistance tests based upon genotype testing |
Phase IV |
Study Type: | Interventional |
Study Design: | Diagnostic, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | A Randomised Comparator Study to Assess the Relative Efficacy of Genotypic Versus Virtual Phenotypic Resistance Tests in Treatment Experienced Patients With HIV Infection for Whom a Change in Therapy is Indicated |
Estimated Enrollment: | 300 |
Study Start Date: | March 2001 |
Estimated Study Completion Date: | August 2002 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Australia, Australian Capital Territory | |
Interchange General Practice | |
Canberra, Australian Capital Territory, Australia | |
Australia, New South Wales | |
AIDS Research Initiative | |
Sydney, New South Wales, Australia, 2010 | |
Albion Street Centre | |
Sydney, New South Wales, Australia, 2010 | |
Holdsworth House General Practice | |
Sydney, New South Wales, Australia, 2010 | |
Sydney Sexual Health Clinic | |
Sydney, New South Wales, Australia, 2000 | |
Royal Prince Alfred Hospital | |
Camperdown, New South Wales, Australia, 2050 | |
St. Vincent's Hospital | |
Sydney, New South Wales, Australia, 2010 | |
Taylor Square Private Clinic | |
Sydney, New South Wales, Australia, 2010 | |
Prince of Wales Hospital | |
Sydney, New South Wales, Australia, 2031 | |
Livingston Road Sexual Health | |
Sydney, New South Wales, Australia | |
Australia, Queensland | |
Cairns Base Hospital | |
Cairns, Queensland, Australia, 4870 | |
Gold Coast Sexual Health Clinic | |
Miami, Queensland, Australia, 4220 | |
QLD Health - AIDS Medical Unit | |
Brisbane, Queensland, Australia, 4002 | |
Australia, South Australia | |
Care and Prevention Programme | |
Adelaide, South Australia, Australia | |
Australia, Victoria | |
Alfred Hospital | |
Melbourne, Victoria, Australia, 3004 | |
Melbourne Sexual Health Centre | |
Melbourne, Victoria, Australia, 3053 | |
Prahran Market Clinic | |
Melbourne, Victoria, Australia, 3141 | |
Australia, Western Australia | |
Fremantle Hospital | |
Fremantle, Western Australia, Australia, 6160 | |
Royal Perth Hospital | |
Perth, Western Australia, Australia, 6000 |
Study Chair: | Sean Emery, PhD | The National Centre in HIV Epidemiology and Clinical Research at the University of New South Wales |
Study ID Numbers: | TVRP9901, ACTR012605000781640 |
Study First Received: | December 6, 2005 |
Last Updated: | June 8, 2006 |
ClinicalTrials.gov Identifier: | NCT00262717 |
Health Authority: | Australia: Department of Health and Ageing Therapeutic Goods Administration |
HIV drug resistance testing Treatment Experienced |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
Communicable Diseases RNA Virus Infections Slow Virus Diseases |
Immune System Diseases Lentivirus Infections Infection |